Skip to main content
Andrew Saxon, MD, Allergy & Immunology, Los Angeles, CA

AndrewSaxonMD

Allergy & Immunology Los Angeles, CA

Executive Director, Food and Drug Allergy Care Center; Physician, Clinical Immunology and Allergy; Professor Emeritus, Medicine; Clinical Immunology and Allergy, UCLA School of Medicine

Dr. Saxon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Saxon's full profile

Already have an account?

  • Office

    UCLA Medical Ctr
    10833 LeConte Ave
    Los Angeles, CA 90095
    Phone+1 310-367-9736

Education & Training

  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1972 - 1975
  • Harvard Medical School
    Harvard Medical SchoolClass of 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1973 - 2026
  • American Board of Allergy and Immunology Allergy & Immunology
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Diagnostic Laboratory Immunology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Therapeutic And Anti-Inflammatory Effects Of Phase II "Anti-Oxidant" InductionNational Institute Of Allergy And Infectious Diseases2007–2008
  • Allergy Therapy With Chimeric Human IG ProteinsNational Institute Of Allergy And Infectious Diseases2003–2007
  • Therapeutic Anti-Inflammatory Phase II "Anti-Oxidant"National Institute Of Allergy And Infectious Diseases2006
  • Clinical And Fundamental ImmunologyNational Institute Of Allergy And Infectious Diseases1990–2006
  • Xenobiotics And Allergic InflammationNational Institute Of Allergy And Infectious Diseases2001–2005
  • Blocking Xenobiotic And Allergen InflammationNational Institute Of Allergy And Infectious Diseases2001–2002
  • Regulation Of IGE In Health And DiseaseNational Institute Of Allergy And Infectious Diseases1994–2002
  • Xenobiotics And Allergic InflammationNational Institute Of Allergy And Infectious Diseases1997–2000
  • Modulation Of The Human IGE Response By XenobioticsNational Institute Of Allergy And Infectious Diseases1997–2000
  • Chimeric MRNA Templates Drive AIDS B Cell LymphomasNational Cancer Institute1998–1999
  • Regulation Of B Cell Differentiation In Common Variable Immunodeficiency--Cd40National Cancer Institute1994–1998
  • Regulation Of IGE In Health And DiseaseNational Institute Of Allergy And Infectious Diseases1997
  • Core--Scid-Hu Mouse/Human Chimera Core FacilityNational Institute Of Allergy And Infectious Diseases1994–1997
  • Molecular Regulation Of Allergic Immune InflammationNational Institute Of Allergy And Infectious Diseases1996
  • Venoglobulin R-S Safety And Efficacy In Primary Immune DeficienciesNational Center For Research Resources1996
  • Modulation Of The Human IGE Response By Polycyclic Aromatic HydrocarbonsNational Institute Of Allergy And Infectious Diseases1994–1996
  • Molecular Regulation Of Allergic-Immune InflammationNational Institute Of Allergy And Infectious Diseases1993–1996
  • Venoglobulin R-S Safety And Efficacy In Subjects With Primary Immune DeficienciesNational Center For Research Resources1995
  • IrradiatorNational Center For Research Resources1995
  • Regulation Of Human IGE In Health And DiseaseNational Institute Of Allergy And Infectious Diseases1985–1993
  • Triatoma Protracta HypersensitivityNational Institute Of Allergy And Infectious Diseases1985
  • Therapy In Immunodeficiency SymdromesNational Center For Research Resources1985
  • L.V. Infusion Of Modified Serum Immunoglobulin--Immunodeficiency SyndromeNational Center For Research Resources1985
  • Immune Reconstitution Following B.M. TransplantationNational Cancer Institute1985
  • Control Of The Human B Cell Response By Genomic MechanismsNational Cancer Institute1985

Professional Memberships